Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ploysyne Rattanakaemakorn, Prinpat Pinyowiwat, Wimolsiri Iamsumang, Kumutnart Chanprapaph & Poonkiat Suchonwanit. (2021) Incidence and Risk Factors of Hepatic Fibrosis in Psoriatic Patients Receiving Methotrexate with Concomitant Acitretin Therapy and Methotrexate Monotherapy. Drug Design, Development and Therapy 15, pages 2299-2307.
Read now
Read now
I Belinchón, R Rivera, C Blanch, M Comellas & L Lizán. (2016) Adherence, satisfaction and preferences for treatment in patients with psoriasis in the European Union: a systematic review of the literature. Patient Preference and Adherence 10, pages 2357-2367.
Read now
Read now
Giampiero Girolomoni, Gianfranco Altomare, Fabio Ayala, Enzo Berardesca, Piergiacomo Calzavara-Pinton, Sergio Chimenti, Andrea Peserico, Antonio Puglisi Guerra & Gino Antonio Vena. (2012) Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis. Immunopharmacology and Immunotoxicology 34:4, pages 548-560.
Read now
Read now
Jonathan P Staidle, Tushar S Dabade & Steven R Feldman. (2011) A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opinion on Pharmacotherapy 12:13, pages 2041-2054.
Read now
Read now
Brad A. Yentzer & Steven R. Feldman. (2011) Trends in home phototherapy adoption in the US: Monetary disincentives are only the tip of the iceberg. Journal of Dermatological Treatment 22:1, pages 27-30.
Read now
Read now
Kate E. Lowenthal, Pamela J. Horn & Robert E. Kalb. (2008) Concurrent use of methotrexate and acitretin revisited. Journal of Dermatological Treatment 19:1, pages 22-26.
Read now
Read now
Rotraut Mössner & Kristian Reich. (2006) Infliximab in the treatment of psoriasis. Expert Review of Dermatology 1:4, pages 515-526.
Read now
Read now
Articles from other publishers (25)
Narumol Silpa‐archa, Penvadee Pattanaprichakul, Norramon Charoenpipatsin, Natchaya Jansuwan, Suthipol Udompunthurak, Leena Chularojanamontri & Chanisada Wongpraparut. (2019) The efficacy of UVA1 phototherapy in psoriasis: Clinical and histological aspects. Photodermatology, Photoimmunology & Photomedicine 36:1, pages 21-28.
Crossref
Crossref
Jonathan G. Bonchak & Peter A. Lio. (2020) Nonpharmacologic interventions for chronic pruritus. Itch 5:1, pages e31-e31.
Crossref
Crossref
Liisa Väkevä, Sirkka Niemelä, Meri Lauha, Rafael Pasternack, Anna Hannuksela‐Svahn, Anna Hjerppe, Adrienn Joensuu, Minna Soronen, Lasse Ylianttila, Riikka Pastila, Hannu Kautiainen, Erna Snellman, Mari Grönroos & Toni Karppinen. (2019) Narrowband ultraviolet B phototherapy improves quality of life of psoriasis and atopic dermatitis patients up to 3 months: Results from an observational multicenter study. Photodermatology, Photoimmunology & Photomedicine 35:5, pages 332-338.
Crossref
Crossref
Kavita Goyal, Michael O. Nguyen, Rachel V. Reynolds, Arash Mostaghimi, Cara Joyce, Jeffrey M. Cohen & Elizabeth A. Buzney. (2017) Perceptions of U.S. dermatology residency program directors regarding the adequacy of phototherapy training during residency. Photodermatology, Photoimmunology & Photomedicine 33:6, pages 321-325.
Crossref
Crossref
Emőke Rácz & Errol P. Prens. 2017. Ultraviolet Light in Human Health, Diseases and Environment. Ultraviolet Light in Human Health, Diseases and Environment
287
294
.
Abigail Cline & Jake E. Turrentine. (2016) Biomedical and Market Issues Surrounding the Advent of Biosimilars. Dermatology and Therapy 6:3, pages 341-345.
Crossref
Crossref
Lorenzo Mantovani, Massimo Medaglia, Patrizio Piacentini, Marcella Tricca, Gino Antonio Vena, Antonietta Vozza, Gabriella Castellino & Alessandro Roccia. (2016) Burden of Moderate-to-Severe Plaque Psoriasis and New Therapeutic Approaches (Secukinumab): An Italian Perspective. Dermatology and Therapy 6:2, pages 151-167.
Crossref
Crossref
Rahul Kapoor & Thomas Klueter. (2015) Decoding the Adaptability–Rigidity Puzzle: Evidence from Pharmaceutical Incumbents’ Pursuit of Gene Therapy and Monoclonal Antibodies. Academy of Management Journal 58:4, pages 1180-1207.
Crossref
Crossref
Leire González-Lara, Ana Batalla, Eliecer Coto, Juan Gómez, Noemí Eiris, Jorge Santos-Juanes, Rubén Queiro & Pablo Coto-Segura. (2014) The TNFRSF1B rs1061622 polymorphism (p.M196R) is associated with biological drug outcome in Psoriasis patients. Archives of Dermatological Research 307:5, pages 405-412.
Crossref
Crossref
Henry W. Lim, Narumol Silpa-archa, Ugochukwu Amadi, Alan Menter, Abby S. Van Voorhees & Mark Lebwohl. (2015) Phototherapy in dermatology: A call for action. Journal of the American Academy of Dermatology 72:6, pages 1078-1080.
Crossref
Crossref
Federico Spandonaro, Fabio Ayala, Enzo Berardesca, Sergio Chimenti, Giampiero Girolomoni, Patrizia Martini, Andrea Peserico, Barbara Polistena, Antonio Puglisi Guerra, Gino Antonio Vena, Gianfranco Altomare & Piergiacomo Calzavara Pinton. (2014) The Cost Effectiveness of Biologic Therapy for the Treatment of Chronic Plaque Psoriasis in Real Practice Settings in Italy. BioDrugs 28:3, pages 285-295.
Crossref
Crossref
A. Mustonen, K. Mattila, M. Leino, L. Koulu & R. Tuominen. (2014) Psoriasis Causes Significant Economic Burden to Patients. Dermatology and Therapy 4:1, pages 115-124.
Crossref
Crossref
Caitriona Ryan, Neil J. Korman, Joel M. Gelfand, Henry W. Lim, Craig A. Elmets, Steven R. Feldman, Alice B. Gottlieb, John Y.M. Koo, Mark Lebwohl, Craig L. Leonardi, Abby S. Van Voorhees, Reva Bhushan & Alan Menter. (2014) Research gaps in psoriasis: Opportunities for future studies. Journal of the American Academy of Dermatology 70:1, pages 146-167.
Crossref
Crossref
Anssi Mustonen, Kalle Mattila, Mauri Leino, Leena Koulu & Risto Tuominen. (2013) The Costs of Psoriasis Medications. Dermatology and Therapy 3:2, pages 169-177.
Crossref
Crossref
Reginald Villacorta, Joel W. Hay & Andrew Messali. (2013) Cost Effectiveness of Moderate to Severe Psoriasis Therapy with Etanercept and Ustekinumab in the United States. PharmacoEconomics 31:9, pages 823-839.
Crossref
Crossref
Christine S. Ahn, Cheryl J. Gustafson, Laura F. Sandoval, Scott A. Davis & Steven R. Feldman. (2013) Cost Effectiveness of Biologic Therapies for Plaque Psoriasis. American Journal of Clinical Dermatology 14:4, pages 315-326.
Crossref
Crossref
Chong-Fai Mok, Chuan-Ming Xie, Kathy Wai-Yan Sham, Zhi-Xiu Lin & Christopher Hon-Ki Cheng. (2013) 1,4-dihydroxy-2-naphthoic Acid Induces Apoptosis in Human Keratinocyte: Potential Application for Psoriasis Treatment. Evidence-Based Complementary and Alternative Medicine 2013, pages 1-19.
Crossref
Crossref
Frank A. Santoro, Marti J. Rothe & Bruce E. Strober. (2012) Ethical considerations when prescribing biologics in dermatology. Clinics in Dermatology 30:5, pages 492-495.
Crossref
Crossref
Alan Menter, Neil J. Korman, Craig A. Elmets, Steven R. Feldman, Joel M. Gelfand, Kenneth B. Gordon, Alice Gottlieb, John Y.M. Koo, Mark Lebwohl, Craig L. Leonardi, Henry W. Lim, Abby S. Van Voorhees, Karl R. Beutner, Caitriona Ryan & Reva Bhushan. (2011) Guidelines of care for the management of psoriasis and psoriatic arthritis. Journal of the American Academy of Dermatology 65:1, pages 137-174.
Crossref
Crossref
Robert J. Sage & Henry W. Lim. (2010) UV-based therapy and vitamin D. Dermatologic Therapy 23:1, pages 72-81.
Crossref
Crossref
Ulrich Mrowietz & Kristian Reich. (2009) Ten years of infliximab: Its role in dermatology. European Journal of Pharmacology 623, pages S10-S16.
Crossref
Crossref
S. Sizto, N. Bansback, S.R. Feldman, M.K. Willian & A.H. Anis. (2009) Economic evaluation of systemic therapies for moderate to severe psoriasis. British Journal of Dermatology 160:6, pages 1264-1272.
Crossref
Crossref
Lars Alexander Schneider, Ralf Hinrichs & Karin Scharffetter-Kochanek. (2008) Phototherapy and photochemotherapy. Clinics in Dermatology 26:5, pages 464-476.
Crossref
Crossref
Rotraut Mössner, Michael P. Schön & Kristian Reich. (2008) Tumor necrosis factor antagonists in the therapy of psoriasis. Clinics in Dermatology 26:5, pages 486-502.
Crossref
Crossref
Jerry K.L. Tan. (2016) Challenges and Solutions in Selecting Systemic Antipsoriatic Agents. Journal of Cutaneous Medicine and Surgery 11:2_suppl, pages S48-S53.
Crossref
Crossref